Completed PHASE4 INTERVENTIONAL 2-arm NCT01191593

The Efficacy of Adductor-Canal-Blockade on Pain and Morphine Consumption After Revision Knee Arthroplasty

Sponsor: Rigshospitalet, Denmark

Conditions Knee Arthroplasty Postoperative Pain

Interventions Adductor-Canal-Blockade with Ropivacaine Adductor-Canal-blockade with saline

Updated 5 times since 2017 Last updated: Aug 21, 2013 Started: Sep 30, 2010 Primary completion: Apr 30, 2013 Completion: Apr 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01191593, this PHASE4 trial focuses on Knee Arthroplasty and Postoperative Pain and remains completed. Sponsored by Rigshospitalet, Denmark, it has been updated 5 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rigshospitalet, Denmark

Data source: Rigshospitalet, Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Copenhagen, Denmark